Heart failure in adults:
If you take more Blopress than you should
If you have taken more Blopress than prescribed by your doctor, contact your doctor or pharmacist immediately. You can also call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Blopress
Do not take a double dose to compensate for the missed doses. Simply take the next dose.
If you interrupt treatment with Blopress
If you stop taking Blopress, your blood pressure may increase again. Therefore, do not stop taking Blopress before consulting your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may have side effects, although not everyone will experience them. It is essential that you know which side effects could occur.
Stop taking Blopress and see your doctor immediately if you experience any of the following allergic reactions:
Blopress may cause a decrease in white blood cells. Your resistance to infections may decrease, and you may feel tired, have an infection, or fever. If this occurs, inform your doctor. It is possible that your doctor will perform a blood test at regular intervals to check if Blopress is affecting your blood (agranulocytosis).
Other possible side effects include:
Frequent (affects 1 to 10 of every 100 patients)
Very rare (affects less than 1 in 10,000 patients)
-A decrease in sodium levels in the blood. If severe, you may feel weak, lack energy, or experience muscle cramps.
Not known (cannot be estimated based on available data)
In children treated for high blood pressure, side effects appear to be similar to those observed in adults, but occur more frequently. Additionally, sore throat is a very common side effect in children, and nasal discharge, fever, and increased heart rate are common in children.
Reporting side effects
If you experience any type of side effect, consult your doctor, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use:www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Blopress
The active ingredient of Blopress is candesartan cilexetilo.Each tablet contains 32 mg of candesartan cilexetiloThe other components arecalcium carmelose, hydroxypropylcellulose, lactose monohydrate, magnesium stearate, cornstarch and macrogol.
Appearance of the product and contents of the packaging
Blopress 32 mg tablets are round, pale pink tablets with convex faces, one of which is marked with 32 and the other is scored.
Blopress is available in polypropylene or PVC/PVDC/Alu blisters.
Each pack contains 28, 30, 56 or 98 tablets.
Only some pack sizes may be marketed.
Marketing authorization holder and manufacturer responsible
Marketing authorization holder:
CHEPLAPHARM Arzneimittel GmbH
Ziegelhof 24
17489 Greifswald
Germany
Manufacturer responsible:
Delpharm Novara S.r.l., Via Crosa 86 (Cerano) I-28065, Italy
Lusomedicamenta – Sociedade Técnica Farmacêutica, S.A.Rua Norberto de Oliveira 1 a 5, 2620-111 Póvoa de Sto. Adrião, Portugal.
Lusomedicamenta – Sociedade Técnica Farmacêutica, S.A.
Estrada Consiglieri Pedroso 66, 69-B, Queluz de Baixo
2730-055 Barcarena
Portugal
Local Representative:
Laboratorios Rubió, S.A.
Industria, 29 – Pol. Ind. Comte de Sert
08755 Castellbisbal (Barcelona)
Spain
This medicinal product is authorized in the Member States of the European Economic Area with the following names:
Member State | Name |
Austria, Germany, Ireland, Italy, Portugal, Spain | Blopress |
France | Kenzen |
Last review date of this leaflet:March 2025
Other sources of information
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.